Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FFR-Guided Revascularization in Atherosclerotic Renal Artery Stenosis
NCT07511309Recruiting
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- May 2026
- Primary completion
- May 2027
- Countries
- 1
01
Overview
Randomised, open-label trial in atherosclerotic renal artery stenosis (ARAS) and hypertension (HTN) (3 arms), sponsored by Chinese Academy of Medical Sciences. Primary endpoint: Estimated Glomerular Filtration Rate at 12 months. Started May 2026; status: recruiting.
02
Conditions
atherosclerotic renal artery stenosis (ARAS)hypertension (HTN)
Beyond the preview
Go deeper on NCT07511309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07511309.